MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cullinan Therapeutics (CGEM) Ownership - Who owns Cullinan Therapeutics?
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
483.82M
P/E Ratio
N/A
Total Cash
265.48M
Projected Growth
N/A
Total Debt
1.52M
Revenue
N/A
Risk (Beta)
-0.02
Dividend Yield
N/A
Total Cash/Share
4.49
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGEM
Capitalization
484M
P/E Ratio
N/A
Risk (Beta)
-0.02
Dividend Yield
N/A
Total Cash
265M
Total Cash/Share
4.49
Total Debt
1.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
492M
P/B Ratio
0.98
Cash Flow
N/A
Earnings
-3.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
9.83
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-234.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.42
Shares Held By Institutions
581M
Shares Outstanding - Current
59.1M
Total Liabilities
28.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-32.759
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEM showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com